Advertisement

Ads Placeholder
Loading...

Scilex Holding Company

SCLXNASDAQ
Healthcare
Drug Manufacturers - General
$7.13
$-0.31(-4.17%)
U.S. Market opens in 1h 19m

Scilex Holding Company (SCLX) Stock Overview

Explore Scilex Holding Company’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap60.9M
P/E Ratio-0.23
EPS (TTM)$-40.46
ROE1.81%
Fundamental Analysis

AI Price Forecasts

1 Month$-2.10
3 Months$11.45
1 Year Target$22.10

SCLX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Scilex Holding Company (SCLX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.08, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $22.10.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.23 and a market capitalization of 60.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-4.17%
5-Day Change
7.87%
1-Month Change
-15.92%
3-Month Change
-45.57%
6-Month Change
-57.61%
Year-to-Date (YTD) Change
-45.53%
1-Year Change
-18.05%
3-Year Change
-98.42%
5-Year Change
-97.94%
All-Time (Max) Change
-97.93%

Contact Information

650-516-4310
960 San Antonio Road, Palo Alto, CA, 94303

Company Facts

1,150 Employees
IPO DateMar 5, 2021
CountryUS
Actively Trading

Frequently Asked Questions